These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11355935)

  • 1. Flasks, fibres and flanks--pre-clinical tumour models for predicting clinical antitumour activity.
    Newell DR
    Br J Cancer; 2001 May; 84(10):1289-90. PubMed ID: 11355935
    [No Abstract]   [Full Text] [Related]  

  • 2. [New approaches in experimental cancerology: in search of therapeutic models].
    Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Pierré A; Hickman J
    Bull Cancer; 2001 Jan; 88(1):75-84. PubMed ID: 11182656
    [No Abstract]   [Full Text] [Related]  

  • 3. [In vitro systems for the primary search for biologically active substances with carcinostatic action].
    Egorov LV; Chernov VA; Sokolova AS
    Eksp Onkol; 1988; 10(4):11-7. PubMed ID: 3053148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S; Wittes R
    Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antitumor drug screening at the National Cancer Institute, U.S.A].
    Tsuruo T
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2809-15. PubMed ID: 3310904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the National Cancer Institute in drug development.
    Doroshow J
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):257-8. PubMed ID: 16166997
    [No Abstract]   [Full Text] [Related]  

  • 7. Developing new agents for the treatment of childhood cancer.
    Kurmasheva R; Morton C; Houghton PJ
    Curr Opin Investig Drugs; 2005 Dec; 6(12):1215-27. PubMed ID: 16372407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hollow fibre model in cancer drug screening: the NCI experience.
    Decker S; Hollingshead M; Bonomi CA; Carter JP; Sausville EA
    Eur J Cancer; 2004 Apr; 40(6):821-6. PubMed ID: 15120037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental evaluation of antitumor drugs in the USA and USSR and clinical correlations.
    Natl Cancer Inst Monogr; 1980 Dec; (55):1-179. PubMed ID: 7010179
    [No Abstract]   [Full Text] [Related]  

  • 10. New initiatives aim to test more cancer drugs for children.
    Brower V
    J Natl Cancer Inst; 2004 Dec; 96(24):1808-10. PubMed ID: 15601634
    [No Abstract]   [Full Text] [Related]  

  • 11. New anticancer agents: in vitro and in vivo evaluation.
    Zips D; Thames HD; Baumann M
    In Vivo; 2005; 19(1):1-7. PubMed ID: 15796152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NCI Developmental Therapeutics Program.
    Collins JM
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):271-3. PubMed ID: 16728938
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro drug resistance versus chemosensitivity: two sides of different coins.
    Fruehauf JP; Alberts DS
    J Clin Oncol; 2005 May; 23(15):3641-3; author reply 3646-8. PubMed ID: 15908686
    [No Abstract]   [Full Text] [Related]  

  • 14. [Soviet-American cooperation in experimental and clinical chemotherapy from 1972 to 1979].
    Peredovchikova NI; Kiselev AV; Puchkov IuI; Komarova LE; Gorbunova VA
    Vopr Onkol; 1980; 26(12):3-6. PubMed ID: 7008350
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapeutic strategies for neoplasia.
    Talmadge JE
    Dev Biol Stand; 1992; 77():17-28. PubMed ID: 1426659
    [No Abstract]   [Full Text] [Related]  

  • 16. NCI launches an innovative design for a breast cancer clinical trial.
    Whitworth A
    J Natl Cancer Inst; 2006 Sep; 98(17):1178-9. PubMed ID: 16954467
    [No Abstract]   [Full Text] [Related]  

  • 17. Stat bite: Treatment trials in the PDQ clinical trials database, by phase.
    J Natl Cancer Inst; 2004 Sep; 96(18):1355. PubMed ID: 15367566
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening at the National Cancer Institute.
    Goldin A; Venditti JM; Carter SK
    Natl Cancer Inst Monogr; 1977 Mar; (45):37-48. PubMed ID: 337155
    [No Abstract]   [Full Text] [Related]  

  • 19. Mining the NCI screening database: explorations of agents involved in cell cycle regulation.
    Wallqvist A; Monks A; Rabow AA; Thanki N; Shoemaker RH; Covell DG
    Prog Cell Cycle Res; 2003; 5():173-9. PubMed ID: 14593711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose intensity versus total dose of chemotherapy: an experimental basis.
    Skipper HE
    Important Adv Oncol; 1990; ():43-64. PubMed ID: 2182523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.